Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03231527Withdrawn

Outcomes of Total Arterial Coronary Artery Bypass Grafting

Role: collaborator

NCT02074566Not ApplicableCompleted

Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study

Role: collaborator

NCT03197298Completed

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Role: lead

NCT02625493Completed

Patient Preference for Radial Versus Femoral Vascular Access

Role: lead

NCT02508714Not ApplicableUnknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

Role: lead

NCT02175706Not ApplicableUnknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity

Role: lead

NCT02189070Completed

The PAtient Preference Analysis of Yearly Follow-up After PCI (PAPAYA)

Role: lead

All 7 trials loaded